Nuclear Medicine: Page 33

Novartis touts prostate cancer study results at ASCO 2021

By AuntMinnie.com staff writers

Novartis highlighted results presented at the virtual American Society of Clinical Oncology meeting that suggest lutetium-177 prostate-specific membrane antigen-617 is safe and effective for patients with PSMA-positive metastatic prostate cancer.

June 7, 2021

Physicists want ban on radioactive alternative medicine pendants

By Will Morton

A group of Malaysian physicists are recommending a ban on so-called "scalar energy" pendants after finding that the alternative medicine trinkets are actually embedded with radioactive isotopes, according to a study published June 1 in Plos One.

June 6, 2021

SNMMI offers letter to contest SPECT/CT denials

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published a letter template for healthcare providers to use to contest coverage denials of SPECT/CT exams.

June 2, 2021

ImaginAb lands $13M in growth funding

By AuntMinnie.com staff writers

Radiopharmaceutical developer ImaginAb has raised almost $13 million in funding to support the company's growth and further development of its CD8 Immuno-PET agent.

June 2, 2021

Fusion Pharmaceuticals to build radiopharma plant in Canada

By AuntMinnie.com staff writers

McMaster University spin-off company Fusion Pharmaceuticals announced it has entered a 15-year lease agreement with the school for a new manufacturing facility for therapeutic pharmaceuticals near its campus in Hamilton, Ontario.

June 2, 2021

'Early frame' PET may reduce cost and burden in Alzheimer's disease

By Will Morton

PET imaging of patients to detect Alzheimer's disease may be effective in minutes rather than hours after they are injected with a radiotracer, according to research published May 28 in the Journal of Nuclear Medicine. The finding suggests "early frame" PET may reduce imaging costs and burden on patients and their families.

June 1, 2021

Blue Earth touts Axumin results in Lancet

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting results of a study published in Lancet showing that postprostatectomy radiation therapy guided by the company's PET radiotracer Axumin (fluciclovine F-18) helped increase biochemical event-free survival rates in men with recurrent prostate cancer.

May 26, 2021

PET/MRI advances efforts for virtual biopsy in breast cancer

By Will Morton

FDG-PET/MRI combined with ultrasound could reduce the need for invasive biopsy to confirm suspicious findings in women with newly diagnosed metastatic breast cancer, according to a study by German researchers published May 20 in the Journal of Nuclear Medicine.

May 25, 2021

ARTMS reports milestone in Ga-68 production

By AuntMinnie.com staff writers

ARTMS has produced multiple curies of gallium-68 (Ga-68) after a two-hour bombardment on a U.S. cyclotron that has been used mainly for F-18 FDG production.

May 24, 2021

NorthStar partners with Clarity, Monopar

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and radiopharmaceutical firm Clarity Pharmaceuticals are joining forces on the supply of the therapeutic radioisotope copper-67. NorthStar is also partnering with biopharmaceutical firm Monopar Therapeutics on a patent.

May 24, 2021

SNMMI urges Congress to continue support for medical research

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is urging Congress to support medical research with infrastructure investments.

May 23, 2021

Shine selects Netherlands site for new facility

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies announced it has selected a location in the northern Netherlands for its new production facility.

May 19, 2021

Previous Page

Page 33 of 438

Next Page